The big shareholder groups in Genus plc (LON:GNS) have power over the company. Generally speaking, as a company grows, institutions will increase their ownership. Conversely, insiders often decrease ...

Under the guidance of CEO Stephen Wilson, Genus plc (LON:GNS) has performed reasonably well recently. In light of this performance, CEO compensation will probably not be the main focus for ...

Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks! Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks The latest update is out from Genus ...

Genus plc (GB:GNS) has released an update. Genus PLC has notified on May 31, 2024, of a change in major shareholdings after Ameriprise Financial, Inc. adjusted its position. The notification comes ...

Greenwood Investors LLC entered the stock in 2024 after spending material time with its new CEO, Jorgen Kokke. Genus Plc is a uniquely positioned animal genetics company that remains under-appreciated ...

It's been a good week for Genus plc (LON:GNS) shareholders, because the company has just released its latest half-yearly results, and the shares gained 9.7% to UK£19.59. Revenues came in 3.6% below ...

Genus Plc engages in the provision of genetic livestock services to produce meat and milk. It operates through the following segments: Genus PIC, Genus ABS, and Genus Research and Development. The ...

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings. The information provided on PharmiWeb.com is ...